Function of the IL-2R for thymic and peripheral CD4+CD25+ Foxp3+ T regulatory cells
- PMID: 17371960
- DOI: 10.4049/jimmunol.178.7.4062
Function of the IL-2R for thymic and peripheral CD4+CD25+ Foxp3+ T regulatory cells
Abstract
IL-2 contributes to the production, function, and homeostasis of CD4+CD25+ T(reg) cells. However, it remains uncertain whether IL-2 is essential for the development of T(reg) cells in the thymus, their homeostasis in the periphery, or both. The present study was undertaken to investigate the contribution of IL-2 during thymic T(reg) cell development and its maintenance in peripheral immune tissue. Relying on genetic mouse models where IL-2R signaling was either completely blocked or selectively inhibited in peripheral CD4+CD25+ T(reg) cells, we show that the IL-2/IL-2R interaction is active in the thymus at the earliest stage of the development of T(reg) cells to promote their expansion and to up-regulate Foxp3 and CD25 to normal levels. Furthermore, CD4+CD25+Foxp3+ T(reg) cells with impaired IL-2-induced signaling persist in the periphery and control autoimmunity without constant thymic output. These peripheral T(reg) cells with poor responsiveness to IL-2 exhibited slower growth and extended survival in vivo, somewhat lower suppressive activity, and poor IL-2-dependent survival in vitro. Mixed thymic and bone marrow chimeric mice showed that wild-type-derived T(reg) cells were substantially more effective in populating peripheral immune tissue than T(reg) cells with impaired IL-2 signaling. Collectively, these data support the notion that normally IL-2 is a dominant mechanism controlling the number of thymic and peripheral T(reg) cells.
Similar articles
-
A function for IL-7R for CD4+CD25+Foxp3+ T regulatory cells.J Immunol. 2008 Jul 1;181(1):225-34. doi: 10.4049/jimmunol.181.1.225. J Immunol. 2008. PMID: 18566388 Free PMC article.
-
Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells.Nat Med. 2005 Nov;11(11):1238-43. doi: 10.1038/nm1312. Epub 2005 Oct 16. Nat Med. 2005. PMID: 16227988
-
Rapamycin, not cyclosporine, permits thymic generation and peripheral preservation of CD4+ CD25+ FoxP3+ T cells.Bone Marrow Transplant. 2007 May;39(9):537-45. doi: 10.1038/sj.bmt.1705628. Epub 2007 Mar 12. Bone Marrow Transplant. 2007. PMID: 17351648
-
Guarding the immune system: suppression of autoimmunity by CD4+CD25+ immunoregulatory T cells.Immunol Cell Biol. 2006 Dec;84(6):487-501. doi: 10.1111/j.1440-1711.2006.01471.x. Epub 2006 Sep 5. Immunol Cell Biol. 2006. PMID: 16956386 Review.
-
CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus.Arch Dermatol Res. 2009 Jan;301(1):71-81. doi: 10.1007/s00403-008-0891-9. Epub 2008 Nov 5. Arch Dermatol Res. 2009. PMID: 18985367 Review.
Cited by
-
Immunomodulation Followed by Antigen-Specific Treg Infusion Controls Islet Autoimmunity.Diabetes. 2020 Feb;69(2):215-227. doi: 10.2337/db19-0061. Epub 2019 Nov 11. Diabetes. 2020. PMID: 31712320 Free PMC article.
-
Stability of the regulatory T cell lineage in vivo.Science. 2010 Sep 24;329(5999):1667-71. doi: 10.1126/science.1191996. Science. 2010. PMID: 20929851 Free PMC article.
-
Targeting Regulatory T Cells for Therapy of Lupus Nephritis.Front Pharmacol. 2022 Jan 6;12:806612. doi: 10.3389/fphar.2021.806612. eCollection 2021. Front Pharmacol. 2022. PMID: 35069220 Free PMC article. Review.
-
Weekly injection of IL-2 using an injectable hydrogel reduces autoimmune diabetes incidence in NOD mice.Diabetologia. 2021 Jan;64(1):152-158. doi: 10.1007/s00125-020-05314-1. Epub 2020 Oct 30. Diabetologia. 2021. PMID: 33125521 Free PMC article.
-
In vivo suppression of naive CD4 T cell responses by IL-2- and antigen-stimulated T lymphocytes in the absence of APC competition.J Immunol. 2008 Sep 1;181(5):3323-35. doi: 10.4049/jimmunol.181.5.3323. J Immunol. 2008. PMID: 18714004 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials